Team-based support to improve blood sugar with continuous glucose monitors
Team Support to Improve Glycemic Control Using CGM in Diverse Populations (TEAM CGM)
This project offers continuous glucose monitors plus support from pharmacists and community health workers to adults with type 2 diabetes in low-income and minority communities to help them better control blood sugar and avoid lows.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11323061 on NIH RePORTER |
What this research studies
You would use a continuous glucose monitor and mobile health tools while a care team of clinical pharmacists and community health workers reviews your glucose data, helps with medications, and addresses social needs. The study plans to enroll about 318 adults with type 2 diabetes who are not using insulin in primary care clinics. It uses a Sequential Multiple Assignment Randomized Trial (SMART) design so the level or type of team support can change based on how well your blood sugar responds. The work is done in partnership with local community health centers and family medicine clinics.
Who could benefit from this research
Good fit: Adults with type 2 diabetes who are not on insulin and who receive care at participating community or family medicine clinics, especially those facing socioeconomic barriers, are the ideal candidates.
Not a fit: People using insulin, those with type 1 diabetes, or individuals who cannot attend participating clinics are unlikely to be eligible or directly benefit from this project.
Why it matters
Potential benefit: If successful, this approach could help people in underserved communities lower A1c, increase time spent in a healthy glucose range, and reduce hypoglycemia.
How similar studies have performed: Randomized trials have shown CGM can lower A1c and improve time-in-range—particularly for people on insulin—but using CGM together with community health worker and pharmacist teams in low-income, non-insulin T2DM populations is a newer approach.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Gerber, Ben Steven — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Gerber, Ben Steven
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.